Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Audeara Ltd. ( (AU:AUA) ) has issued an announcement.
Audeara has secured purchase orders from Taiwan-based Clinico Inc., initiating three new white-label commercial programs that will see Auracast-enabled devices, packaging, accessories and a programming tool sold under the Clinico brand. The initial orders, worth about $164,000, build on the earlier launch of Clinico Sound Earbuds in Taiwan and are positioned as a key step in scaling Audeara’s AUA Technology division through integrations into partner product ecosystems.
Central to the expansion is Audeara’s BT-03 Audio Broadcaster, recently launched in Australia at a $399 price point and designed to provide Auracast broadcast infrastructure for shared audio in public and commercial venues. Early stocking by AV installers and consumer audio retailers, plus ongoing certification for the U.S., Japan, Taiwan, Canada and the EU, suggests the product could open new international sales channels and support broader revenue growth as Auracast adoption increases.
The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.
More about Audeara Ltd.
Audeara Ltd. is an Australian audio technology company focused on hearing health and personalised listening solutions. Its portfolio includes Auracast-enabled devices, audio broadcasters, earbuds and transceivers, with a growing emphasis on white-label integrations and international commercial partnerships, particularly in Asia-Pacific and other major global markets.
Average Trading Volume: 610,189
Technical Sentiment Signal: Buy
Current Market Cap: A$13.39M
Find detailed analytics on AUA stock on TipRanks’ Stock Analysis page.